Covestor’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Covestor’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	-$1K	–	2846
2022 Q2	$1K	Sell	6 -2	-25%	-$89	﹤0.01%	1834
2022 Q1	$0	Sell	8 -2	-20%	-$67	﹤0.01%	2555
2021 Q4	$1K	Buy	+10	New	+$447	﹤0.01%	2054

Covestor's TPTX Position: Q3 2022 in Review

Covestor sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 6 shares — an estimated $1K sold.

Covestor first reported a position in TPTX in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Covestor reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Covestor sold 6 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
Covestor first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
Covestor's Turning Point Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Covestor's 13F filing for Q3 2022, filed 14 Nov 2022.